Thrombophilia Treatment Market Size

Thrombophilia Treatment Market size was over USD 16.74 billion in 2023 and is anticipated to reach USD 39.37 billion by 2036, growing at around 6.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of thrombophilia treatment is estimated at USD 17.65 billion. The growth of the market can be attributed to the growing burden of obesity, and increasing prevalence of cardiovascular and trauma cases across the world. According to the World Health Organization, as of now, cardiovascular diseases account for about 17.9 million deaths, which is an estimated 32 percent of all the deaths globally.

Along with these, rise in consumption of alcohol and tobacco is predicted to add a risk of development of high blood pressure on veins leading to several thrombophilia complications, which in turn is expected to fuel the market growth in the upcoming years. Furthermore, escalating research and development spending in the field of hematological diseases, and government initiatives to raise awareness regarding blood disorders are projected to offer profitable opportunities to the market in the near future.